Table 4.

Univariate analysis evaluating the association among potential laboratory tests and adverse outcome

	Favorable outcome	Adverse outcome	p
Blood laboratory tests
White blood cell count (x 10^9/L)	7.59 ± 4.55	7.30 ± 3.42	0.658
White blood cell count < 4000 (x 10^9/L)	12 (8.8%)	6 (12%)	0.382
Hemoglobin (g/L)	13.23 ± 1.84	12.32 ± 2.03	0.022
Hemoglobin < 10 g/L	5 (3.3%)	6 (12%)	0.011
Platelet count (x 10^9/L)	216.19 ± 80.69	181.74 ± 70.21	0.007
Platelet count < 100 (x 10^9/L)	6 (4%)	6 (12%)	0.076
Lymphocyte count (x 10^9/L)	1.08 ± 0.55	0.77 ± 0.38	0.003
INR	1.25 ± 0.42	1.38 ± 0.36	0.453
D-dimer (ng/mL)	857.72 ± 471.35	1905.14 ± 1945.89	0.003
Alanine aminotransferase (U/L)	40.46 ± 28.59	33.79 ± 28	0.296
Creatine kinase (U/L)	354.27 ± 1256.58	196.76 ± 211.92	0.437
Lactate dehydrogenase (U/L)	310.41 ± 109.99	393.2 ± 210.97	0.022
Lactate dehydrogenase > 300 U/L*	24 (18,4%)	20 (54%)	<0.001
Ferritin (ng/mL)	1309.39 ± 1618.34	2993.55 ± 4026.43	0.001
Ferritin > 500 ng/mL	88 (58.6%)	23 (46%)	0.809
Ferritin >1000 ng/mL	56 (37.3%)	17 (24%)	0.241
Ferritin >3000 ng/mL	6 (4%)	10 (20%)	<0.001
CRP (mg/L)	119.41 ± 86.83	119.7 ± 86.03	0.985

INR: international normalized ratio; CRP: C reactive protein.

* data evaluated on a total of 167 patients.